Test Overview
Clinical Utility
Voltage-Gated Potassium Channel (VGKC) Antibody, CSF – VGKC antibody may be detected in acquired neuromyotonia, Morvans syndrome, autoimmune limbic encephalitis, autonomic dysfunction, peripheral nerve hyperexcitability, chronic idiopathic pain, and in SIADH.
Method
Radioimmunoassay (RIA)
Result Included
Voltage-Gated Potassium Channel (VGKC) Antibodies
Specimen
Specimen Type
CSFVolume
Sample Volume
1.0 mL
Minimum Volume
0.5 mL
Collection & Handling
Collection Instructions
Collect in sterile, leak-proof container.
Handling Information
Store and send frozen
Stability
| Ambient | Refrigerated | Frozen |
|---|---|---|
| 48 hours | 14 days | 28 days |
Performance & Interpretation
Turnaround Time
14 days
Results
Name
Units
Reference Range
Conversion
-
Voltage-Gated Potassium Channel (VGKC) Antibodiespmol/L<20
Referral Location
Out-of-Country
Interface & Setup
HL7 Interface Codes
| Order Code | Result Name | Result Codes | Units |
|---|---|---|---|
| VGKC CSF | VOLTAGE GATED POTASSIUM CHANNEL (VGKC) AB | 63124 | pmol/L |
Test Version
Last Updated
2019-11-28